Class information for:
Level 1: HEPATOCYTE GROWTH FACTOR//C MET//HGF

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
303 3689 42.7 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
317 3       HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA 39408
2452 2             HEPATOCYTE GROWTH FACTOR//C MET//HGF 4045
303 1                   HEPATOCYTE GROWTH FACTOR//C MET//HGF 3689

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HEPATOCYTE GROWTH FACTOR authKW 2938862 21% 45% 788
2 C MET authKW 2606410 15% 55% 571
3 HGF authKW 1054922 9% 40% 318
4 MET authKW 729814 7% 34% 262
5 SCATTER FACTOR authKW 537032 3% 68% 96
6 C MET INHIBITOR authKW 353079 1% 89% 48
7 NK4 authKW 335150 1% 90% 45
8 HGF SF authKW 292996 2% 61% 58
9 HEPATOCYTE GROWTH FACTOR HGF authKW 266702 2% 46% 70
10 MOL REGENERAT MED address 258721 2% 36% 87

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 12814 31% 0% 1158
2 Cell Biology 4177 19% 0% 688
3 Biochemistry & Molecular Biology 1869 22% 0% 820
4 Gastroenterology & Hepatology 1035 6% 0% 215
5 Pathology 675 4% 0% 166
6 Medicine, Research & Experimental 658 6% 0% 226
7 Biophysics 514 5% 0% 198
8 Chemistry, Medicinal 337 4% 0% 133
9 Genetics & Heredity 317 5% 0% 196
10 Urology & Nephrology 239 3% 0% 115

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MOL REGENERAT MED 258721 2% 36% 87
2 COURSE ADV MED 230999 1% 57% 49
3 KRINGLE PHARMA JOINT REGENERAT DRUG DISCO 169732 1% 71% 29
4 TUMOR DYNAM REGULAT 93996 1% 41% 28
5 ONCOL BIOCHEM 83599 1% 42% 24
6 BIOCHEMBIOMED 66204 0% 100% 8
7 IRCC 45096 1% 24% 23
8 EXPT CLIN MOL ONCOL 40546 0% 70% 7
9 CANC TREATMENT IRCC 37162 1% 22% 20
10 ANTITUMOR PHARMACOL 32190 1% 13% 30

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOGENE 5186 3% 1% 108
2 CLINICAL CANCER RESEARCH 3532 2% 1% 81
3 MOLECULAR CANCER THERAPEUTICS 3517 1% 1% 42
4 CURRENT SIGNAL TRANSDUCTION THERAPY 3072 0% 4% 9
5 HEPATOLOGY 2094 2% 0% 56
6 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2094 4% 0% 137
7 JOURNAL OF THORACIC ONCOLOGY 1594 1% 1% 23
8 CLINICAL & EXPERIMENTAL METASTASIS 1462 1% 1% 19
9 CANCER RESEARCH 1325 2% 0% 83
10 GROWTH FACTORS 1240 0% 1% 11

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 HEPATOCYTE GROWTH FACTOR 2938862 21% 45% 788 Search HEPATOCYTE+GROWTH+FACTOR Search HEPATOCYTE+GROWTH+FACTOR
2 C MET 2606410 15% 55% 571 Search C+MET Search C+MET
3 HGF 1054922 9% 40% 318 Search HGF Search HGF
4 MET 729814 7% 34% 262 Search MET Search MET
5 SCATTER FACTOR 537032 3% 68% 96 Search SCATTER+FACTOR Search SCATTER+FACTOR
6 C MET INHIBITOR 353079 1% 89% 48 Search C+MET+INHIBITOR Search C+MET+INHIBITOR
7 NK4 335150 1% 90% 45 Search NK4 Search NK4
8 HGF SF 292996 2% 61% 58 Search HGF+SF Search HGF+SF
9 HEPATOCYTE GROWTH FACTOR HGF 266702 2% 46% 70 Search HEPATOCYTE+GROWTH+FACTOR+HGF Search HEPATOCYTE+GROWTH+FACTOR+HGF
10 HEPATOCYTE GROWTH FACTOR SCATTER FACTOR 218559 1% 61% 43 Search HEPATOCYTE+GROWTH+FACTOR+SCATTER+FACTOR Search HEPATOCYTE+GROWTH+FACTOR+SCATTER+FACTOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 CHRISTENSEN, JG , BURROWS, J , SALGIA, R , (2005) C-MET AS A TARGET FOR HUMAN CANCER AND CHARACTERIZATION OF INHIBITORS FOR THERAPEUTIC INTERVENTION.CANCER LETTERS. VOL. 225. ISSUE 1. P. 1-26 179 87% 306
2 GHERARDI, E , BIRCHMEIER, W , BIRCHMEIER, C , WOUDE, GV , (2012) TARGETING MET IN CANCER: RATIONALE AND PROGRESS.NATURE REVIEWS CANCER. VOL. 12. ISSUE 2. P. 89 -103 114 66% 504
3 JIANG, W , HISCOX, S , MATSUMOTO, K , NAKAMURA, T , (1999) HEPATOCYTE GROWTH FACTOR SCATTER FACTOR, ITS MOLECULAR, CELLULAR AND CLINICAL IMPLICATIONS IN CANCER.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 29. ISSUE 3. P. 209 -248 241 71% 183
4 MOLNARFI, N , BENKHOUCHA, M , FUNAKOSHI, H , NAKAMURA, T , LALIVE, PH , (2015) HEPATOCYTE GROWTH FACTOR: A REGULATOR OF INFLAMMATION AND AUTOIMMUNITY.AUTOIMMUNITY REVIEWS. VOL. 14. ISSUE 4. P. 293 -303 131 73% 15
5 FUNAKOSHI, H , NAKAMURA, T , (2003) HEPATOCYTE GROWTH FACTOR: FROM DIAGNOSIS TO CLINICAL APPLICATIONS.CLINICA CHIMICA ACTA. VOL. 327. ISSUE 1-2. P. 1-23 144 89% 126
6 COMOGLIO, PM , GIORDANO, S , TRUSOLINO, L , (2008) DRUG DEVELOPMENT OF MET INHIBITORS: TARGETING ONCOGENE ADDICTION AND EXPEDIENCE.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 6. P. 504 -516 96 77% 417
7 MAROUN, CR , ROWLANDS, T , (2014) THE MET RECEPTOR TYROSINE KINASE: A KEY PLAYER IN ONCOGENESIS AND DRUG RESISTANCE.PHARMACOLOGY & THERAPEUTICS. VOL. 142. ISSUE 3. P. 316 -338 138 64% 35
8 PETERS, S , ADJEI, AA , (2012) MET: A PROMISING ANTICANCER THERAPEUTIC TARGET.NATURE REVIEWS CLINICAL ONCOLOGY. VOL. 9. ISSUE 6. P. 314 -326 101 76% 120
9 VAN DER VOORT, R , TAHER, TEI , DERKSEN, PWB , SPAARGAREN, M , VAN DER NEUT, R , PALS, ST , (2000) THE HEPATOCYTE GROWTH FACTOR/MET PATHWAY IN DEVELOPMENT, TUMORIGENESIS, AND B-CELL DIFFERENTIATION.ADVANCES IN CANCER RESEARCH, VOL 79. VOL. 79. ISSUE . P. 39-90 234 58% 72
10 CUI, JJ , (2014) TARGETING RECEPTOR TYROSINE KINASE MET IN CANCER: SMALL MOLECULE INHIBITORS AND CLINICAL PROGRESS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 11. P. 4427 -4453 107 66% 43

Classes with closest relation at Level 1


Rank Class id link
1 23172 RON//MACROPHAGE STIMULATING PROTEIN//RON RECEPTOR
2 33803 MACC1//METASTASIS ASSOCIATED IN COLON CANCER 1//METASTASIS ASSOCIATED IN COLON CANCER 1 MACC1
3 15913 MATRIPTASE//CORIN//HEPSIN
4 6669 LIVER REGENERATION//PARTIAL HEPATECTOMY//RAT GENOME 230 20 ARRAY
5 35392 RED FISIOPATOL ENFERMEDADES HEPAT//ANTI APOPTOTIC SIGNALLING//BIOQUIM BIOL MOL MIXTO
6 24089 PROLIFERATION CULTURED HEPATOCYTE//DUNN OSTEOSARCOMA CELLS//S 1 2 DICARBOXYETHYLGLUTATHIONE
7 19429 KERATINOCYTE GROWTH FACTOR//KGF//KERATINOCYTE GROWTH FACTOR RECEPTOR
8 13462 HER2//GASTRIC CANCER//HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
9 36195 EPIMORPHIN//MORPHOREGULAT//EPM PROJECT GRP
10 5267 CRIZOTINIB//ANAPLASTIC LYMPHOMA KINASE//ALK

Go to start page